GL1X · GenesisL1 explorer

Research workbench

Influenza virus (VN1194) H5 I155F mutant ha

Analyse Influenza virus (VN1194) H5 I155F mutant ha in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ZPA
Type
protein
Length
479 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hemagglutinin
UniProt
Q6DQ34
Ligands
NAG
Pockets
2 · best druggability 0.59

Structure

x-ray diffraction · 2 distinct chains · 24% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
EHemagglutininprotein32110% helix, 40% strandQ6DQ34
FHemagglutininprotein15854% helix, 15% strandQ6DQ34

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains E

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12930.590.7843empty
2640.450.8215empty

Interfaces

1 interface between chains.

  • E–F · 2447 Ų buried · 37 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 3ZPA · INFLUENZA VIRUS (VN1194) H5 I155F mutant HA · the same entry in another collection · chain E against E, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.